Iridex (IRIX) EBIT Margin Growth (1y) (2011 - 2026)

Iridex (IRIX) EBIT Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -430.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 128.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 301.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 102.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 851.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 241.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -313.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Iridex 15.93 Mn 11.33 Mn 4.74 Mn -102.00

Historic Data

Download Data
DateValue
Apr 4, 2026 -102.00
Jan 3, 2026 385.00
Sep 27, 2025 484.00
Jun 28, 2025 1,396.00
Mar 29, 2025 2,628.00
Dec 28, 2024 2,078.00
Sep 28, 2024 -301.00
Jun 29, 2024 163.00
Mar 30, 2024 -1,090.00
Dec 30, 2023 -1,545.00
Sep 30, 2023 -155.00
Jul 1, 2023 -681.00
Apr 1, 2023 -9.00
Dec 31, 2022 -509.00
Oct 1, 2022 468.00
Jul 2, 2022 -723.00
Apr 2, 2022 -161.00
Oct 2, 2021 471.00
Jul 3, 2021 3,629.00
Apr 3, 2021 293.00